Michel Joseph Bublot

This inventor holds 28 USPTO granted patents and 7 published patent applications, plus 8 CIPO patents and 14 EPO patents, primarily in Avian Vaccines. Top assignees: Merial Limited, Boehringer Ingelheim Animal Health USA Inc., Rhone Merieux. Active years: 1998-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michel Joseph Bublot. Retrieved from https://idiyas.com/inventor/michel-joseph-bublot

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 8 (Patent Applications = 1)

EPO Patents = 14 (Patent Applications = 19)

Average Co-Inventor Count = 3.7

ph-index = 6

Forward Citations = 262(Granted Patents)

Location History:

Saint-Genis-Les-Ollieres, FR (1998 - 2000)
St-Genis-les-Ollieres, FR (1999 - 2000)
Les Olieres, FR (2000)
St Genis les Olieres, FR (2001)
Delmar, NY (US) (2002 - 2007)
Chaponost, BE (2011)
Chaponost, FR (2013 - 2022)

Company Filing History:

Boehringer Ingelheim Animal Health USA Inc.

Biolex Therapeutics, Inc.

University of Georgia Research Foundation Inc

patents

7. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2025

Loading Chart...

Areas of Expertise:

Recombinant HVT Vectors

Avian Pathogens

Newcastle Disease Virus

Marek's Disease Virus

Avian Influenza Vaccine

Feline Vaccines

Equine GM-CSF

Porcine Circovirus

Live Recombinant Vaccine

Vaccines Development

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12385068 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2025-08-12),

2. 12280106 - Modified Marek's disease virus, and vaccines made therefrom (2025-04-21),

3. 11510978 - Modified Marek's disease virus, and vaccines made therefrom (2022-11-29),

4. 11421249 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2022-08-23),

5. 10822620 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2020-11-03),

6. 10350286 - Newcastle disease virus vectored avian vaccines (2019-07-16),

7. 10323257 - Recombinant HVT vectors expressing multiple antigens of avian pathogens and uses thereof (2019-06-18),

8. 9770502 - Recombinant gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof (2017-09-26),

9. 9616118 - Newcastle disease virus vectored avian vaccines (2017-04-11),

10. 9555096 - Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof (2017-01-31),

11. 9446118 - Newcastle disease virus vectored herpesvirus vaccines (2016-09-20),

12. 9114108 - Recombinant HVT vectors expressing antigens of avian pathogens and uses thereof (2015-08-25),

13. 9101598 - Recombinant Gallid herpesvirus 3 (MDV serotype 2) vectors expressing antigens of avian pathogens and uses thereof (2015-08-11),

14. 8986706 - Newcastle disease virus vectored herpesvirus vaccines (2015-03-24),

15. 8871220 - Newcastle disease virus vectored avian vaccines (2014-10-28),

Title: Inventor Michel Joseph Bublot

Introduction: Michel Joseph Bublot is a renowned inventor hailing from St-Genis-les-Ollieres, France. He has made significant contributions to the field of innovation with his groundbreaking inventions.

Latest Patents: Michel Joseph Bublot holds several patents in various technological areas, showcasing his versatility and creativity in inventing new solutions to existing problems.

Career Highlights: Throughout his career, Michel Joseph Bublot has been recognized for his innovative spirit and dedication to pushing the boundaries of technology. His inventions have had a lasting impact on industries ranging from healthcare to telecommunications.

Collaborations: Michel Joseph Bublot has collaborated with leading research institutions and companies to bring his inventions to life. His ability to work with diverse teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Michel Joseph Bublot stands as a visionary inventor whose passion for innovation continues to inspire others in the field. His contributions have left a lasting legacy in the world of technology and beyond.

Profile summary based on public USPTO records.